microRNA replacement in malignant pleural mesothelioma

Personalised cancer medicine using the human protein atlas and affibodies

IDH1 mutation in haemato-oncology

EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer

Novel drug targets and potential combinations in childhood brain tumours

Gdf -11 a new target to improve anaemia in thalassemia

Advances in multiple myeloma: Expert discussion

Biomarkers in CLL prognosis

Philadelphia chromosome and the role it plays in chronic myeloid leukaemia

Investigating anticarcinogenic compounds as an alternative to chemo

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC

HPV-targeted adoptive T Cell therapy may provide a new personalised strategy for advanced cervical cancer